Janney Montgomery Scott
IMGN

Janney Montgomery Scott’s Immunogen Inc IMGN Stock Holding History

Janney Montgomery Scott’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-42,326
Closed -$202K – 2663
2022
Q3 		$202K Buy
42,326
+1,023
+2% +$5.39K ﹤0.01% 2286
2022
Q2 		$186K Sell
41,303
-6,735
-14% -$29.3K ﹤0.01% 2161
2022
Q1 		$229K Sell
48,038
-10,181
-17% -$56.4K ﹤0.01% 2021
2021
Q4 		$432K Buy
58,219
+11,438
+24% +$71.1K ﹤0.01% 1811
2021
Q3 		$265K Sell
46,781
-4,061
-8% -$23.5K ﹤0.01% 2023
2021
Q2 		$335K Buy
50,842
+630
+1% +$4.39K ﹤0.01% 1858
2021
Q1 		$407K Sell
50,212
-574
-1% -$4.69K ﹤0.01% 1681
2020
Q4 		$328K Sell
50,786
-3,088
-6% -$18K ﹤0.01% 1837
2020
Q3 		$194K Sell
53,874
-21
-0% -$85 ﹤0.01% 1920
2020
Q2 		$248K Sell
53,895
-3,519
-6% -$15K ﹤0.01% 1732
2020
Q1 		$196K Sell
57,414
-3,670
-6% -$16K ﹤0.01% 1682
2019
Q4 		$312K Sell
61,084
-1,663
-3% -$5.64K ﹤0.01% 1690
2019
Q3 		$152K Sell
62,747
-13,577
-18% -$36K ﹤0.01% 1948
2019
Q2 		$166K Buy
76,324
+147
+0.2% +$348 ﹤0.01% 1943
2019
Q1 		$206K Sell
76,177
-1,710
-2% -$7.41K ﹤0.01% 1852
2018
Q4 		$374K Sell
77,887
-8,525
-10% -$51.7K ﹤0.01% 1451
2018
Q3 		$818K Buy
86,412
+1,835
+2% +$17.6K 0.01% 1158
2018
Q2 		$823K Buy
84,577
+4,799
+6% +$50.6K 0.01% 1092
2018
Q1 		$839K Buy
79,778
+5,089
+7% +$50.3K 0.01% 1044
2017
Q4 		$479K Buy
74,689
+17,250
+30% +$106K 0.01% 1322
2017
Q3 		$439K Sell
57,439
-1,345
-2% -$8.94K 0.01% 1325
2017
Q2 		$418K Sell
58,784
-31
-0.1% -$142 0.01% 1272
2017
Q1 		$228K Buy
58,815
+5,893
+11% +$17.2K ﹤0.01% 1551
2016
Q4 		$108K Buy
52,922
+7,823
+17% +$15.7K ﹤0.01% 1618
2016
Q3 		$121K Buy
+45,099
New +$131K ﹤0.01% 1455
2016
Q2 		– Sell
-32,401
Closed -$276K – 1214
2016
Q1 		$276K Buy
+32,401
New +$274K 0.01% 1003

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Janney Montgomery Scott's IMGN Position: Q4 2022 in Review

Janney Montgomery Scott sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 42,326 shares — an estimated $202K sold.

Janney Montgomery Scott first reported a position in IMGN in Q1 2016 and held it in 26 quarters. The position peaked at $839K in Q1 2018. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Janney Montgomery Scott reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Janney Montgomery Scott sold 42,326 Immunogen Inc shares in Q4 2022, an estimated $202K.
  • Janney Montgomery Scott first reported a position in Immunogen Inc in Q1 2016 and held it in 26 quarters.
  • Janney Montgomery Scott's Immunogen Inc position peaked at $839K in Q1 2018.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Janney Montgomery Scott's 13F filing for Q4 2022, filed 1 Feb 2023.